⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 11, 2020JAMA

Therapy for Early COVID-19

Peter Kim Sarah W. Read Anthony S. Fauci

View at Publisher

Ask AI

Bookmark

Share

Abstract

James M. Sanders, PhD, PharmD; Marguerite L. Monogue, PharmD; Tomasz Z. Jodlowski, PharmD; James B. Cutrell, MD

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kim et al. (2020) studied this question.

synapsesocial.com/papers/6aa808b621935eeb407137e8 https://doi.org/10.1001/jama.2020.22813

View at Publisher

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Corticosteroids in COVID-19 ARDSOriginal Research · 2020 · 196 citations
2Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19Meta-Analysis · 2020 · 2,256 citations
3Obesity in Children Aged 2 to 12 YearsJAMA · Wed,
4Reassessing Lumbar Punctures for Very Young Febrile Infants—How Much Evidence Is Enough?JAMA · Wed,
5Nonfatal Drug Overdoses and Naloxone UseJAMA · Wed,

More from JAMA

What Is Childhood Obesity?Wed,
Metabolic Dysfunction–Associated Steatotic Liver Disease in Children and AdolescentsWed,
National and County-Level Trends in Opioid DispensingWed,
Childhood Cancer Risk After Assisted Reproductive TechnologyWed,
JamaTue,